Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Clinical trial NCT02119650 · TERMINATED

Trial details

NCT number: NCT02119650
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Carcinoma)

Start date: 2014-02-11
Primary completion: 2016-02-11
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.